US Patent 10870837 Fusion proteins comprising enzyme replacement therapy enzymes
Patent 10870837 was granted and assigned to Denali Therapeutics on December, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 15, 2019
0
Date of Patent
December 22, 2020
0
Patent Applicant
Patent Application Number
16355339
0
Patent Citations
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10870837 Fusion proteins comprising enzyme replacement therapy enzymes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
